| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/23/2001 | WO2001060863A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy |
| 08/23/2001 | WO2001060862A1 Vasoactive intestinal peptide analogs |
| 08/23/2001 | WO2001060832A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 08/23/2001 | WO2001060819A1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 08/23/2001 | WO2001060816A1 Kinase inhibitors |
| 08/23/2001 | WO2001060814A2 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/23/2001 | WO2001060813A1 Beta-alanine derivatives and their use as receptor antagonists |
| 08/23/2001 | WO2001060810A1 Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity |
| 08/23/2001 | WO2001060808A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 08/23/2001 | WO2001060807A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001060784A1 Aniline-derived ligands for the thyroid receptor |
| 08/23/2001 | WO2001060458A2 Inhibitors of prenyl-protein transferase |
| 08/23/2001 | WO2001060417A2 Radioactive therapeutic liposomes |
| 08/23/2001 | WO2001060412A2 Modification of biopolymers for improved drug delivery |
| 08/23/2001 | WO2001060408A2 Microcompetiton and human disease |
| 08/23/2001 | WO2001060397A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | WO2001060391A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 08/23/2001 | WO2001060381A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/23/2001 | WO2001060379A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 08/23/2001 | WO2001060374A1 Use of paullone derivatives for making medicines |
| 08/23/2001 | WO2001060365A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 08/23/2001 | WO2001060363A1 A method for synthesizing leflunomide |
| 08/23/2001 | WO2001060359A1 Physiologic activity of a benzopyran derivative originating from propolis |
| 08/23/2001 | WO2001060355A1 Modulation of bone formation |
| 08/23/2001 | WO2001060354A1 Cancer remedy comprising anthranilic acid derivative as active ingredient |
| 08/23/2001 | WO2001060343A2 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers |
| 08/23/2001 | WO2001060319A2 Polyhydroxylated benzene-containing compounds |
| 08/23/2001 | WO2001060317A2 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 08/23/2001 | WO2001060176A1 Inulin products with improved nutritional properties |
| 08/23/2001 | WO2001025422A3 Antisense compositions and cancer-treatment methods |
| 08/23/2001 | WO2001025399A3 Non-invasive tumor imaging by tumor-targeted bacteria |
| 08/23/2001 | WO2001024803A3 Pharmaceutical compositions containing copper, salicylic acid and vitamines c |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001012215A3 Protective antigen of Epstein barr virus |
| 08/23/2001 | WO2001008704A3 Dendrimer-photosensitizer complexes for medical applications |
| 08/23/2001 | WO2001007436A3 Substituted oxoazaheterocyclyl compounds |
| 08/23/2001 | WO2001007029A3 Substituted guanidines and the use thereof |
| 08/23/2001 | WO2000078954A3 Human transcriptional regulator proteins |
| 08/23/2001 | WO2000078266A3 Interferon tau mutants and methods for making them |
| 08/23/2001 | WO2000074634A3 Methods and compositions for modulating cell proliferation and cell death |
| 08/23/2001 | WO2000059484A3 Use of arylalkanoylpyridazines |
| 08/23/2001 | WO2000044364A3 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant |
| 08/23/2001 | US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/23/2001 | US20010016645 Vitazin antibody; treating angiogenesis or restenosis |
| 08/23/2001 | US20010016644 Protein of given molecular weight and given N-terminal amino acid sequence |
| 08/23/2001 | US20010016600 Method of treating cancer using dithiocarbamate derivatives |
| 08/23/2001 | US20010016596 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/23/2001 | US20010016590 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 08/23/2001 | US20010016588 Antiallergens; antitumor agents; anticancer agents |
| 08/23/2001 | US20010016586 Use of organic compounds |
| 08/23/2001 | US20010016585 Antitumor agent |
| 08/23/2001 | US20010016583 Therapeutic application of pro-apoptotic benzodiazepines |
| 08/23/2001 | US20010016575 Antisense modulation of human MDM2 expression |
| 08/23/2001 | US20010016346 Pedtidyl-prolyl cis-trans isomerase inhibitors and uses therefore |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016329 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 08/23/2001 | US20010016207 Compounds such as N-(1-(cyanomethylcarbamoyl)cyclohexyl)-4-(piperazin-1-yl)-benzamide |
| 08/23/2001 | US20010016197 Cultivating a fungi of the basidiomycetes in a submerged culture on nutrient media, isolating the biomass of edible mushrooms from the culture broth, and drying at a range of 40-45 degrees celsius |
| 08/23/2001 | US20010016196 Immunoliposomes that optimize internalization into target cells |
| 08/23/2001 | EP1143944A3 Use of arylalkanoylpyridazines |
| 08/23/2001 | DE10006033A1 New pharmaceutical for immunization against a carcinoma and its preliminary stages contains a cell cycle regulatory protein, particularly the cyclin-dependent kinase inhibitor p16 |
| 08/23/2001 | DE10002820A1 Aminopeptidasen-Inhibitor Aminopeptidase inhibitor |
| 08/23/2001 | CA2405714A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy |
| 08/23/2001 | CA2405689A1 Vasoactive intestinal peptide analogs |
| 08/23/2001 | CA2400862A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 08/23/2001 | CA2400631A1 Beta-alanine derivatives and their use as receptor antagonists |
| 08/23/2001 | CA2400473A1 Her-2 binding antagonists |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400355A1 Pancreatic islet cell growth factors |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400290A1 A method for synthesizing leflunomide |
| 08/23/2001 | CA2400264A1 Cancer remedy comprising anthranilic acid derivative as active ingredient |
| 08/23/2001 | CA2400263A1 Method of controlling telomere length |
| 08/23/2001 | CA2400205A1 Modification of biopolymers for improved drug delivery |
| 08/23/2001 | CA2400197A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 08/23/2001 | CA2400101A1 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | CA2400034A1 Human kinases |
| 08/23/2001 | CA2400021A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/23/2001 | CA2399816A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 08/23/2001 | CA2399810A1 Modulation of bone formation |
| 08/23/2001 | CA2398945A1 Small oligonucleotides with anti-tumor activity |
| 08/23/2001 | CA2398825A1 Gtpase activating proteins |
| 08/23/2001 | CA2397560A1 Use of paullone derivatives for making medicines |
| 08/23/2001 | CA2396793A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | CA2395854A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/23/2001 | CA2395473A1 Microcompetiton and human disease |
| 08/23/2001 | CA2371419A1 Polyhydroxylated benzene-containing compounds |
| 08/22/2001 | EP1126028A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 08/22/2001 | EP1126025A2 Oligonucleotide modulation of protein kinase C |
| 08/22/2001 | EP1125947A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 08/22/2001 | EP1125944A1 Pluraflavin and derivatives thereof, process for making them as well as their use |
| 08/22/2001 | EP1125936A2 Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases |
| 08/22/2001 | EP1125507A1 Inulin products with improved nutritional properties |
| 08/22/2001 | EP1124989A1 Method for determining cancer by determining expression of mage-10 |
| 08/22/2001 | EP1124983A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 08/22/2001 | EP1124982A1 THE HEMATOPOIETIC, MYELOPROTECTING, ANTITUMOR IMMUNE CELLS GENERATING AND RADIOSENSITIZING POLYSACCHARIDE ISOLATED FROM i PANAX GINSENG /i |
| 08/22/2001 | EP1124977A1 Modified adenoviral fibre and uses thereof |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |